scispace - formally typeset
Open AccessJournal ArticleDOI

Cardiovascular disease and risk factors in Asia: a selected review.

Reads0
Chats0
TLDR
The existence of higher stroke rates and lower CHD rates in Asian countries than in Western countries and the respective risk factors for this are discussed on the basis of extensive reviews of cohort studies and whether these risk factors differ from those of Western countries are discussed.
Abstract
Cardiovascular disease (CVD) prevention in Asia is an important issue for world health, because half of the world’s population lives in Asia. Asian countries and regions such as Japan, the Republic of Korea, the People’s Republic of China, Hong Kong, Taiwan, and the Kingdom of Thailand have greater mortality and morbidity from stroke than from coronary heart disease (CHD), whereas the opposite is true in Western countries.1 The reasons why this specific situation is observed in countries with rapid and early-phase westernization, such as Japan and South Korea, are very interesting. The Seven Countries Study conducted by Keys et al2 in 1957 found that Japanese populations had lower fat intake, lower serum total cholesterol, and lower CHD than populations in the United States and Scandinavia, in spite of higher smoking rates. The serum total cholesterol level in Japan has increased rapidly since World War II in accordance with an increase in dietary fat intake from 10% of total energy intake per capita per day to 25%.1,2 Despite this increase, the specific characteristic of lower CHD incidence and mortality than that in Western countries has persisted.3,4 Whether Japanese people and certain other Asian populations have different risk factors for CHD than Western populations has been a subject of discussion for quite some time. In this article, we discuss the existence of higher stroke rates and lower CHD rates in Asian countries than in Western countries and the respective risk factors for this on the basis of extensive reviews of cohort studies. We also discuss whether these risk factors differ from those of Western countries. Along with this, we examine the relationship between serum total cholesterol and total stroke and its subtypes. We also address the emerging problems and important issues for CVD prevention in Asia. An extensive …

read more

Citations
More filters
Journal ArticleDOI

Cross-sectional association of equol producing status with aortic calcification in Japanese men aged 40–79 years

TL;DR: In this article , the authors measured the urinary levels of equol and isoflavone (ISF)-derived metabolite by the gut microbiome in certain individuals termed equol-producers (EP).
Journal ArticleDOI

Practical Cutoff Values of Brachial–Ankle Pulse Wave Velocity to Predict 10-Year CHD Risk in the Japanese General Population

TL;DR: In this paper , the authors examined the relationship between brachial-ankle pulse wave velocity (PWV) and the Framingham risk score (FRS) for predicting the 10-year risk for coronary heart disease (CHD) in Japanese participants.
Journal ArticleDOI

Correction to: Different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7)

TL;DR: In this paper, the authors compared the impact of baseline profiles on the future CVD risk between patients with diabetes with and without a CVD history, and found that the prognostic impact of metabolic profiles on future cardiovascular disease (CVD) risk would not be identical among patients with and non-diabetic patients.
References
More filters
Journal ArticleDOI

Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030

TL;DR: Findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant, and given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.
Journal ArticleDOI

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

TL;DR: Statin therapy can safely reduce the 5-year incidence of major coronary events, coronary revascularisation, and stroke by about one fifth per mmol/L reduction in LDL cholesterol, largely irrespective of the initial lipid profile or other presenting characteristics.
Journal ArticleDOI

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

TL;DR: An analysis of methods and results of coronary event registration in 1985 through 1987 provides data on the relation between CHD morbidity and mortality, and refute suggestions that high CHD mortality rates are associated with high case-fatality rates or a relative excess of sudden deaths.
Journal ArticleDOI

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

TL;DR: There is conclusive evidence from randomised trials that statins substantially reduce not only coronary event rates but also total stroke rates in patients with a wide range of ages and blood pressures.
Related Papers (5)

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more